Early Stage

Delivering the advanced, cost-effective medical devices hospitals need

Delivering the advanced, cost-effective medical devices hospitals need


Raised this Round: Raised: $161,928

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common



SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Year Founded



Healthcare & Pharmaceuticals

Tech Sector



Scottsdale, Arizona

SharpMed is raising funds on Republic. The company makes transformative medical devices and delivers advanced and cost-effective medical devices to hospitals. SharpMed’s flagship product, Turbo O2 Cap, has FDA Class 1 clearance and will work as a lifeline in critical moments by preventing dangerous drops in oxygen levels during intubation. The product of SharpMed is 95% ready and is ready for its commercial launch in 2024. Dr. Chris Salvino founded SharpMed in December 2015. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1.2 million. The campaign proceeds will be used for new product marketing, research and development, new hires, and general working capital.

Summary Profit and Loss Statement

FY 2023 FY 2022












Net Income



Summary Balance Sheet

FY 2023 FY 2022




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 05/22/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
SharpMed on Republic 2024
Platform: Republic
Security Type: Equity - Common
Price per Share: $2.00

Follow company

Follow SharpMed on Republic 2024

Buy SharpMed's Deal Report

SharpMed Deal Report

Get KingsCrowd’s comprehensive report on SharpMed including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether SharpMed is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the SharpMed deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge